We have more than 10 years of experience
To bring new medical treatments & products to the market and help patients with unmet medical needs, we have two pathways. Industrialized produced products for the mass market versus individualized treatments as a medical procedure in a Point of Care setting. Both paths have been successfully developed and introduced products and technology to the market.
The well-established, but much slower drug/pharmaceutical pathway did benefit primarily in the late 19th and early 20th century millions of peoples with the discovery of vaccines, immunosuppressants, NSAID´s, statins to mention a few.
The physician’s pathway already existed in early time, well demonstrated with Hippocrates, around 300 BC, considered the father of medicine. This path especially in the 20th century, paved the way to open heart surgery and IVF, opening up entirely new avenues of medical treatments, which continues on an accelerated path in this early 21st century with cellular and stem cell treatments.
Both pathways have their place in the medical treatment field, while one, the drug-related, is developing therapies in the slow and robust aircraft carrier model, while physicians have a more speedboat mentality as shown in the graph beside. The physician’s pathway is faster because it is different. It starts with observing and discussing individual cases, doing early investigational treatments with individuals, resulting in anecdotal confirmation of safety and efficacy, without using randomized, placebo structured clinical trials. This treatment therapy targets a singular person and is truly personalized. There is no claim that one is better than the other, it’s just different, and a physician also has to invest in an adequate infrastructure to provide the Point of Care treatment.
The drug-related pathway is aiming the mass market and does not target individual cases, though sometimes used in early observational trial. In the drug-related market scenario, companies develop synthetic compounds mimicking natural behavior which later on are industrialized produced and mass-marketed. To confirm safety and efficacy it, therefore, takes much longer to review potential side effects. Nothing wrong with this approach, but it's only one approach to treating patients.
A significant revision in the life sciences illuminates the formerly hidden connection between mind and body. The “new” biology defines how our thoughts, attitudes, and beliefs create our body’s conditions, ranging from health to disease. According to new science, only 1% of disease is due to genetic defects, and the remaining 99% is directly attributable to the environment and our nervous system’s perception of the environment.
Biomechanics of stress, recognized by science to be the primary source of disease and responsible for up to 90% of all doctor office visits, unfortunately, are not treated as such, but patients are usually leaving a doctors office with prescriptions to treat symptoms and not the root cause.
There are many different pathways to improve health and well-being, and we are using a more science-driven holistic approach to develop harmony in the mind-body connection.
To restore the natural regeneration capability and well-being of a body we are increasing the stem cell population. We also are using high tech technologies, like frequency and laser therapies and nutritional support via Telomere and specific mineral supplement combinations. This combination therapy is reflecting the new understanding of how we can heal and maintain health in a human body for many years while aging.
WE ARE CURRENTLY STUDYING
We are studying the following conditions in patient funded medical procedures with the informed consent of patients.
- Cancer (Photodynamic Laser Therapy)
- Interstitial Cystitis
- Motor Neuron Disease
- Multiple Sclerosis
- Optic Nerve Atrophy
- Retinitis Pigmentosa
- Spinal Cord Injury
- Others on request
CellularStem and it's associated treatment centers are not offering stem cell therapy as a cure for any condition, disease, or injury. No statements or implied treatments on this or other related websites, Facebook pages or other social media sites of our organization have been evaluated or approved by the FDA. This website contains no medical advice.
All statements and opinions provided by this and other related company website are provided for educational and informational purposes only, and we do not diagnose or treat via this website or telephone. CellularStem and its associated treatment centers are offering patient-funded research to provide individual patients with Stem Cell Treatments from autologous and allogeneic sources as personalized surgical procedures only, and are not involved in the use or manufacture of any investigational drugs.
CellularStem and its associated clinic partners do not claim that any applications, or potential applications, using stem cells are approved by the FDA, or are even effective. We do not claim that these treatments work for any listed nor unlisted condition, intended or implied. It’s important for potential patients to do their own research based on the options that we present so that one can make an informed decision. Any decision to participate in our patient funded investigational protocols is entirely voluntary.
Who we are
Falk is the Managing Director of CellularStem and a stem cell consultant since 2009 with relationships to various international Stem Cell, Wellness, and Bioelectronic organizations.During his 40 years of corporate activity, he worked as the Managing Director of various subsidiaries of Merck, Germany in Germany, Liechtenstein, Taiwan, South Korea, Malaysia, Singapore, Canada, Hungary, and Portugal. In 2006, he established a foundation, called Fundação Século XXI – Sáude e Vida, to promote science and art, and bringing them together in exhibitions under the umbrella theme of “Esperança de Vida” to sponsor young artists and patients with unmet medical need. In 2009, he established Aristoloft and 2017 CellularStem to develop cellular and stem cell treatment capabilities for European and International patients.
Jasmin is our experienced Patient Coordinator in Delhi. Her experience comprises….
Meet our team
Dr. See is a Board Certified Internist, a Fellow of the American College of...
MD, MS (General Surgery), FRCS (Fellow of the Royal College of Surgeons (Edinburgh) FRCSC...
Qualification MBBS MS (Orthopedic Surgery) Specialization in minimal invasive surgery, Arthroplasty, Spine and Trauma. To...
Dr. Kobinia is an Austrian Surgeon, a Fellow of the „American Association for Thoracic...